Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 16985 | 560 | 40.2 | 79% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1680 | 6226 | MARFAN SYNDROME//FIBRILLIN//LYSYL OXIDASE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | LYSYL OXIDASE | Author keyword | 138 | 55% | 31% | 172 |
| 2 | LOXL2 | Author keyword | 19 | 76% | 2% | 13 |
| 3 | LYSYL OXIDASE LIKE 2 | Author keyword | 15 | 77% | 2% | 10 |
| 4 | HYPOXIA METASTASIS TEAM | Address | 11 | 78% | 1% | 7 |
| 5 | LOXL4 | Author keyword | 9 | 83% | 1% | 5 |
| 6 | LYSYL OXIDASE LIKE | Author keyword | 6 | 80% | 1% | 4 |
| 7 | LYSYL OXIDASE LIKE 4 | Author keyword | 4 | 67% | 1% | 4 |
| 8 | LYSYL OXIDASE LIKE PROTEIN | Author keyword | 4 | 75% | 1% | 3 |
| 9 | CRUK TUMOUR CELL SIGNALLING UNIT | Address | 3 | 100% | 1% | 3 |
| 10 | LOXL | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | LYSYL OXIDASE | 138 | 55% | 31% | 172 | Search LYSYL+OXIDASE | Search LYSYL+OXIDASE |
| 2 | LOXL2 | 19 | 76% | 2% | 13 | Search LOXL2 | Search LOXL2 |
| 3 | LYSYL OXIDASE LIKE 2 | 15 | 77% | 2% | 10 | Search LYSYL+OXIDASE+LIKE+2 | Search LYSYL+OXIDASE+LIKE+2 |
| 4 | LOXL4 | 9 | 83% | 1% | 5 | Search LOXL4 | Search LOXL4 |
| 5 | LYSYL OXIDASE LIKE | 6 | 80% | 1% | 4 | Search LYSYL+OXIDASE+LIKE | Search LYSYL+OXIDASE+LIKE |
| 6 | LYSYL OXIDASE LIKE 4 | 4 | 67% | 1% | 4 | Search LYSYL+OXIDASE+LIKE+4 | Search LYSYL+OXIDASE+LIKE+4 |
| 7 | LYSYL OXIDASE LIKE PROTEIN | 4 | 75% | 1% | 3 | Search LYSYL+OXIDASE+LIKE+PROTEIN | Search LYSYL+OXIDASE+LIKE+PROTEIN |
| 8 | LOXL | 3 | 100% | 1% | 3 | Search LOXL | Search LOXL |
| 9 | LYSYL OXIDASE GENE | 3 | 100% | 1% | 3 | Search LYSYL+OXIDASE+GENE | Search LYSYL+OXIDASE+GENE |
| 10 | LYSYL OXIDASE PROPEPTIDE | 3 | 100% | 1% | 3 | Search LYSYL+OXIDASE+PROPEPTIDE | Search LYSYL+OXIDASE+PROPEPTIDE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MOLECULAR ROLE | 40 | 82% | 4% | 23 |
| 2 | LOX | 20 | 62% | 4% | 21 |
| 3 | LYSYL OXIDASE LIKE 2 | 17 | 100% | 1% | 8 |
| 4 | RRG | 15 | 82% | 2% | 9 |
| 5 | RAS RECISION GENE | 14 | 100% | 1% | 7 |
| 6 | FIBROGENIC CELLS | 12 | 52% | 3% | 17 |
| 7 | BETA AMINOPROPIONITRILE | 12 | 30% | 6% | 33 |
| 8 | HUMAN LYSYL OXIDASE | 12 | 59% | 2% | 13 |
| 9 | MATRIX FORMING ENZYME | 8 | 75% | 1% | 6 |
| 10 | SECRETED LOXL2 | 8 | 100% | 1% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The rationale for targeting the LOX family in cancer | 2012 | 57 | 169 | 55% |
| Paradoxical roles for lysyl oxidases in cancer - A prospect | 2007 | 104 | 129 | 63% |
| Lysyl oxidases: A novel multifunctional amine oxidase family | 2001 | 213 | 109 | 61% |
| Lysyl oxidase: an oxidative enzyme and effector of cell function | 2006 | 181 | 73 | 82% |
| Lysyl oxidase: Properties, regulation and multiple functions in biology | 1998 | 236 | 71 | 73% |
| Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases | 2008 | 45 | 62 | 60% |
| The potential for targeting extracellular LOX proteins in human malignancy | 2013 | 6 | 42 | 79% |
| LOXL2 in epithelial cell plasticity and tumor progression | 2012 | 16 | 76 | 55% |
| Lysyl oxidase in colorectal cancer | 2013 | 4 | 67 | 79% |
| Lysyl oxidases in mammalian development and certain pathological conditions | 2009 | 38 | 80 | 66% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HYPOXIA METASTASIS TEAM | 11 | 78% | 1.3% | 7 |
| 2 | CRUK TUMOUR CELL SIGNALLING UNIT | 3 | 100% | 0.5% | 3 |
| 3 | CANC UK TUMOUR CELL SIGNALLING UNIT | 2 | 40% | 0.7% | 4 |
| 4 | BIOQUIMIDIPAZ | 1 | 50% | 0.2% | 1 |
| 5 | BREAK BREAST CANC | 1 | 50% | 0.2% | 1 |
| 6 | FED RECH 128 | 1 | 50% | 0.2% | 1 |
| 7 | GEN SURGSHANGHAI DIGEST SURG | 1 | 50% | 0.2% | 1 |
| 8 | GENE FUNCT TEAM | 1 | 50% | 0.2% | 1 |
| 9 | IFR 128CNRS | 1 | 50% | 0.2% | 1 |
| 10 | INVEST BIOMED ALBERTO SOLS CONSEJO SUPER INV | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000110082 | SEMICARBAZIDE SENSITIVE AMINE OXIDASE//VASCULAR ADHESION PROTEIN 1//AMINE OXIDASE |
| 2 | 0.0000104577 | ISODESMOSINE//ELASTIN LAMININ RECEPTOR//DESMOSINE |
| 3 | 0.0000088279 | HEREDITARY NEPHROTIC MOUSE ICGN//ICGN MOUSE//ICGN MICE |
| 4 | 0.0000074365 | LYSYL HYDROXYLASE//EHLERS DANLOS SYNDROME TYPE VI//AGEN UNIT |
| 5 | 0.0000068324 | FIBULIN 1//EFEMP1//FIBULIN 3 |
| 6 | 0.0000068216 | TWISTED GASTRULATION//TOLLOID//CHORDIN |
| 7 | 0.0000064694 | ABT KLIN CHEM MED//BONE ARTHRIT CBAR GERIATR MED//DESIGNING FOODS IMPROVE NUTR FOOD SCI HUMAN |
| 8 | 0.0000060961 | PSEUDOEXFOLIATION SYNDROME//EXFOLIATION SYNDROME//PSEUDOEXFOLIATION |
| 9 | 0.0000060358 | CHROMATIN SUPRAORGANIZATION//NUCLEAR PHENOTYPES//HUMAN BREAST EPITHELIAL CELLS |
| 10 | 0.0000046500 | ELASTIC TISSUE TEARS//BIOENGINEERING FATIGUE//MURAL ATROPHY |